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ABSTRACT 
OBJECTIVE – To compare the effect of a bout of high intensity interval training (HIT) 
and a bout of moderate-intensity continuous training (MICT) on glucose levels over a 
24-hour period. 
RESEARCH DESIGN AND METHODS – Fourteen people with type 1 diabetes 
(duration of type 1 diabetes 8.2 ± 1.4 years), all on basal-bolus regimen, completed a 
randomised counterbalanced crossover study. Continuous glucose monitoring was 
used to assess glycaemic control following a single bout of HIT (6 x 1min intervals) 
and 30mins of moderate-intensity continuous training (MICT) on separate days, 
compared to a non-exercise control day (CON). Exercise was undertaken following 
an overnight fast with omission of short-acting insulin. Finger-prick blood glucose 
samples were recorded pre and post-exercise to assess the acute changes in 
glycaemia during HIT and MICT. 
RESULTS – There was no difference in the incidence of or % time spent in 
hypoglycaemia, hyperglycaemia or target range over the 24-hour and nocturnal 
period (24:00-06:00h) between CON, HIT and MICT (P>0.05). Blood glucose 
concentrations were not significantly (P=0.49) altered from pre to post-exercise with 
HIT (+0.39 ± 0.42 mmol/L) or MICT (-0.39 ± 0.66 mmol/L), with no difference 
between exercise modes (P=1.00). 
CONCLUSIONS – HIT or 30 minutes of MICT can be carried out after an overnight 
fast with no increased risk of hypoglycaemia or hyperglycaemia, and provided the 
starting glucose is between 7-14 mmol/L, no carbohydrate is needed for these 
exercises. As HIT is a time-efficient form of exercise, the efficacy and safety of long-
term HIT should now be explored.  
ABREVIATIONS 
HIT – High intensity interval training 
MICT – Moderate intensity continuous training 
CON – Control day of no exercise 
CGMS – Continuous glucose monitor system 
CHO - Carbohydrate 
EXTOD – Exercising for type 1 diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Clinical guidelines recommend that people with type 1 diabetes perform at least 150 
minutes of moderate-intensity physical activity per week (1). However, a single bout 
of moderate-intensity exercise in people with type 1 diabetes is associated with 
marked decreases in blood glucose concentration and increased risk of 
hypoglycaemia (2; 3). The potentially large drop in blood glucose during exercise 
and associated fear of acute and nocturnal hypoglycaemia means that many patients 
avoid exercise (4), putting them at increased risk of cardio-metabolic diseases. 
Clearly, safe and effective alternative forms of exercise that minimise the perceived 
barriers to exercise are needed for people with type 1 diabetes. 
Lack of time has also been cited as an important barrier to exercise in people 
with type 1 diabetes (4). High intensity interval training (HIT), consisting of repeated 
bouts of high intensity exercise interspersed with low-intensity recovery, is purported 
as a time-efficient alternative to traditional moderate-intensity continuous training 
(MICT) in various groups without type 1 diabetes (5). Indeed, because the typical 
weekly training volume during a HIT programme is approximately one third of the 
time commitment required for MICT (6), HIT is able to minimise a perceived “lack of 
time” as a barrier to exercise. Importantly for people with type 1 diabetes, the 
addition of short bursts of high intensity exercise at regular intervals during a bout of 
MICT has been shown to assist in stabilising blood glucose concentration during 
exercise, and can prevent hypoglycaemia during and up to 2 hours post exercise (7; 
8). It is proposed that the increase in catecholamines, growth hormone and cortisol 
during vigorous exercise (>80% ሶܸO2max) helps stabilise the glucose lowering effect of 
MICT (9). Therefore, in people with type 1 diabetes HIT may maintain blood glucose 
concentrations and reduce the risk of hypoglycaemia both during exercise and 
overnight. To date, however, this has not been investigated.  
The current investigation aimed to determine whether HIT maintained glucose 
in the normal range both during exercise and in the 24-hour period following exercise. 
To achieve this aim we examined the effects of a single bout of HIT and MICT 
following an overnight fast, compared to a control day with no exercise, on acute and 
24-hour glucose concentrations in people with type 1 diabetes. Continuous glucose 
monitor data were analysed to assess 24-hour glycaemic control following exercise 
under controlled diet conditions using the most recent guidelines (10). Capillary 
blood sampling was used to assess change in blood glucose concentrations during 
the exercise bouts. We hypothesised that blood glucose concentrations would be 
maintained following HIT and that the incidence and time spent in hypoglycaemia 
would be lower, compared to MICT. 
 
RESEARCH DESIGN AND METHODS  
Fourteen sedentary people with type 1 diabetes (6 men/8 women; age 26 ± 3 years; 
BMI 27.6 ± 1.3 kg·m-2; ሶܸO2peak 30.8 ± 2.0 ml·kg-1·min-1; duration of type 1 diabetes 
8.2 ± 1.4 years) on a basal-bolus insulin regimen completed the study. Exclusion 
criteria were duration of type 1 diabetes <6 months, insulin pump therapy, significant 
history of hyper or hypoglycaemia, obesity (BMI >32 kg·m-2), pregnancy or planning 
pregnancy, uncontrolled hypertension (>180/100 mmHg), angina, autonomic 
neuropathy, taking any medication that affects heart rate, major surgery planned 
within 6 weeks of the study, severe nonproliferative and unstable proliferative 
retinopathy. Testing took place in the laboratory of the School of Sport and Exercise 
Sciences at Liverpool John Moores University. The study was approved by the Black 
Country NHS Research Ethics Committee (West Midlands, UK) and all participants 
gave written informed consent to a protocol conforming to the Declaration of Helsinki.  
 
Pre-experimental procedures 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, 
The Netherlands) to determine maximal aerobic power output (Wmax) and ሶܸO2peak 
using an online gas collection system (MOXUS modular oxygen uptake system, AEI 
technologies, Pittsburgh, PA). This information was used to determine appropriate 
workloads for subsequent exercise trials. The test consisted of 3-minute stages 
starting at 60 W, and the workload was increased by 35 W at each stage until 
subjects could not maintain a cadence of >50 rpm. ሶܸO2peak was taken as the highest 
value achieved over a 15 second recording period. Participants also completed a 
food diary over a minimum of three days in order to calculate their habitual caloric 
and macronutrient intake. 
 
Study design and experimental protocol 
Participants completed a randomised counterbalanced crossover experiment, 
consisting of 3 intervention periods: control day with no exercise (CON), HIT and 
MICT (see Fig. 1 for protocol overview). Each intervention period lasted 24h during 
which the effect of a single session of exercise on subsequent 24h glycaemic control 
and risk of hypoglycaemia were assessed under standardised dietary, but otherwise 
free living conditions. Periods were identical except for the exercise performed. Prior 
to the intervention periods participants had a Dexcom G4 Platinum CGMS (Dexcom, 
San Diego, CA, USA) inserted subcutaneously on the abdomen. Participants were 
trained on how to use the CGMS and instructed to calibrate the device a minimum of 
four times daily using capillary blood tests. Participants were not blinded to the 
CGMS meaning they could see their glucose values. 24h after the CGMS was 
inserted participants completed the control intervention. Participants did not attend 
the laboratory on the control day, but were provided with a standardised diet to 
consume while going about their normal daily activities.  
The standardised diet was matched to each participant’s habitual energy 
intake and consisted of three meals (breakfast, lunch and dinner; 50% CHO; 30% fat; 
20% protein). Participants were instructed to consume these meals at pre-
determined time-points throughout the day. Participants only consumed the food 
provided by the research team during this period. Additional snacks were only 
permitted to prevent hypoglycaemia. The diet was a 2-day rolling diet, matched for 
macronutrient and energy content between days, which ensured that participants 
consumed exactly the same food on the experimental days. Participants were also 
instructed to abstain from caffeine, alcohol and vigorous exercise. Participants 
completed a food diary to confirm that they had eaten the prescribed food at the 
correct times.  
Following the control day participants completed the 2 exercise intervention 
periods in a randomised order separated by at least 48h. The exercise intervention 
periods were identical to the control intervention except participants attended the 
laboratory following an overnight fast and having omitted their short-acting insulin to 
perform a bout of either HIT or MICT. Following the exercise, participants left the 
laboratory and returned to their normal daily activities. As on the control day 
participants were provided with a standardised diet to consume. This diet was 
identical to the control day and participants consumed each meal at the same pre-
determined time-points throughout the day. Insulin dosage was not recorded. 
 
Exercise Protocols 
Both exercise protocols were conducted on a stationary cycle ergometer (Excalibur 
Sport V2.0, Lode, Groningen, The Netherlands), and were preceded by a 
standardised 5 min warm-up at 50W. MICT consisted of 30 minutes continuous 
cycling at a workload equivalent to 65% ሶܸO2peak. HIT consisted of 6 x 1 minute 
intervals at a workload equivalent to 100% ሶܸO2peak, interspersed with 1 minute of rest. 
As such, the total time commitment of the HIT protocol (17 min) was ~half of that of 
the MICT protocol (35 min).  
 
Acute change in blood glucose with exercise 
Blood glucose concentration was recorded before and after exercise through 
capillary fingertip sampling. This was to ensure that blood glucose levels were 
between 7-14 mmol/L, in accordance with the guidelines we developed in the 
Exercising for Type 1 Diabetes (EXTOD) study (11), meaning participants were safe 
to commence exercise and also safe to leave following exercise. If blood glucose 
was <7 mmol/L before exercise, glucose was ingested. If >14 mmol/L, a light walk or 
insulin was advised, as well as checking blood ketones (12).  
 
Statistical analyses 
Continuous glucose monitor data were downloaded from the device using Dexcom 
Studioᵀᴹ software (12.0.4.6). Data from the CGMS were analysed in accordance to 
the International Consensus on Use of Continuous Glucose monitoring guidelines 
(10). A one-way ANOVA with repeated measures was used to assess glycaemic 
control between the three conditions using the following metrics: percentage of time 
in level 1 hypoglycaemia (≤3.9 mmol/L), level 2 hypoglycaemia (≤2.9 mmol/L), time 
in target range (3.9-10 mmol/L) and hyperglycaemia (≥10 mmol/L). Mean glucose 
and glycaemic variability using coefficient of variation were compared between 
conditions. Episodes of level 1 and 2 hypoglycaemia and hyperglycaemia were 
compared between conditions. The 24-hour period was defined as 08:00-08:00h and 
the nocturnal period was defined as 24:00-06:00h. A two factor repeated measures 
ANOVA was used to assess whether there was an acute change in blood glucose 
concentration following HIT and MICT in the fasted state with the within-subject 
factors ‘training mode’ and ‘time point’. All analyses were performed using IBM 
SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. Data are 
presented as mean ± SEM and significance was set at P≤0.05. 
 
RESULTS 
24h glycaemic control 
Glucose data from the CGMS are presented in Table 1 and mean continuous 
glucose monitor traces over the 24-hour period in each condition are shown in Figure 
2. The CGMS data revealed no differences in the time spent in level 1 
hypoglycaemia (≤3.9 mmol/L) over the 24-hour period (P=0.446) or nocturnal period 
(P=0.944) between the CON, HIT and MICT conditions. Similarly, there were no 
differences in the time spent in level 2 hypoglycaemia (≤2.9 mmol/L) between the 
three conditions over the 24-hour period (P=0.518) or nocturnal period (P=0.969). 
There were also no differences in the time spent in target range or hyperglycaemia 
between the three conditions in the 24-hour or nocturnal periods (P>0.05). 
The incidence of level 1 hypoglycaemia over the 24-hour period (P=0.266) 
and nocturnal period (P=0.522) was no different between CON, HIT and MICT. 
There were no differences in the incidence of level 2 hypoglycaemia over the 24-
hour (P=0.837) or nocturnal (P=0.703) period between conditions.  
There was no report of different levels of snacking between the conditions 
during the CGMS period. Three participants arrived to the laboratory with a blood 
glucose of  <7 mmol/L on one trial so consumed ~200ml of Lucozade Sport Orange 
(20g CHO) and no participants arrived with a blood glucose >14 mmol/L.  
 
Acute change in blood glucose concentration 
Blood glucose concentrations did not drop during HIT (+0.39 ± 0.42 mmol/L) or MICT 
(-0.39 ± 0.66 mmol/L) undertaken in the fasted state (P=0.493), with no difference 
between groups (P=1.00; Fig. 3).  
 
CONCLUSIONS 
This study examined the effects of a fasted bout of HIT and MICT on acute and 24-
hour glucose levels in people with type 1 diabetes. The most important novel findings 
are that 1) there was no difference in the effect of HIT on 24-hour glucose compared 
to MICT, 2) both HIT and MICT performed following an overnight fast do not increase 
the incidence or time spent in hypoglycaemia over the 24-hour or nocturnal period in 
comparison to a day of no exercise, and 3) blood glucose concentration remained 
stable during a bout of fasted HIT and MICT. This suggests that, a single bout of HIT 
or 30 minutes of MICT can be carried out after an overnight fast in people with type 1 
diabetes with no increased risk of hypo or hyperglycaemia. In addition, provided the 
starting glucose is between 7-14 mmol/L, carbohydrate is not needed during these 
exercises in the fasted state.  
The current exercise guidelines for people with type 1 diabetes report that 
aerobic exercise decreases blood glucose levels if performed during the postprandial 
period with insulin administration (1). This is supported by a systematic review and 
meta-analysis (3) that aggregated the results from 10 studies to estimate rate of 
change in glucose concentration in response to different types of exercise in people 
with type 1 diabetes. Garcia-Garcia et al. (3) reported that individuals typically 
experience a rapid decline in glycaemia during continuous exercise (-4.43 mmol/L h-1 
on average), whereas the response to intermittent high intensity exercise is more 
varied and dependent on the protocol. In contrast, our results showed that blood 
glucose concentration remained stable during both HIT and MICT, and the CGMS 
data showed no increased risk of hypoglycaemia over the 24-hour period. It is likely 
that our results do not agree with the findings of Garcia-Garcia et al. (3) because our 
study was performed in the morning following an overnight fast whereas their 
analysis did not control for time of day or nutritional status. Indeed, the most marked 
drop in blood glucose among the publications included in their meta-analysis was by 
Yamanouchi et al. (13) who reported a mean drop of 4.3 mmol/L following a 30 
minute walk at <50% ሶܸO2max after breakfast.  
The same exercise guidelines by Colberg et al. (1) recommend that exercising 
while fasted may produce a lesser decrease or even a small increase in blood 
glucose concentration. The evidence to support this recommendation, however, is 
based on only one study that investigated the effects of fasted resistance training on 
glycaemia with no control day as a comparison (14). We now provide the first 
evidence that blood glucose concentrations are stable following both HIT and MICT 
when undertaken after an overnight fast. The findings of the current investigation 
should therefore be used to inform future exercise guidelines.  
The use of CGMS allowed us to compare the complete 24-hour glucose 
profiles under dietary standardisation but otherwise free-living conditions to assess 
whether there is a delayed response in the risk of hypoglycaemia following HIT. Fear 
of hypoglycaemia during and after exercise, as well as during the nocturnal period, is 
a major barrier to exercise for people with type 1 diabetes, so it is essential to 
objectively establish whether exercise increases the risk. Here we found no 
differences in the time spent in level 1 (≤3.9 mmol/L) or 2 (≤2.9 mmol/L) 
hypoglycaemia in both the nocturnal period and 24-hour period following either HIT 
or MICT compared to a day of no exercise. The food diaries that participants 
completed indicated that they consumed the correct food and there was no 
difference in the amount of additional carbohydrate consumed to prevent 
hypoglycaemia between the conditions. 
Based on our findings it appears that exercising following an overnight fast 
before using short-acting insulin helps to maintain blood glucose stability, 
irrespective of the mode or intensity of the exercise, which means that patients do 
not need to consume carbohydrate to avoid hypoglycaemia during exercise. 
However, the effects of longer duration MICT sessions will have to be tested. Future 
research should investigate whether exercising regularly in the fasted state improves 
long-term glycaemic control. Indeed, Kennedy et al. (15) suggested that previous 
research may have failed to show glycaemic benefits of exercise because calorie 
intake and insulin dose around the time of exercise has not been controlled. Here, 
we studied our participants following an overnight fast to try to isolate the effect of 
exercise intensity alone, which is a strength of the study. Future research which 
examines how exercise of different type, intensities and duration carried out in the 
fasted state effects 24-hour glucose control are needed to help to produce more 
flexible exercise guidelines for people with type 1 diabetes.  
This is the first study to investigate the effects of HIT on glycaemia in people 
with type 1 diabetes. The results suggest that HIT in the fasted state offers a time-
efficient exercise mode that does not increase the risk of hypoglycaemia, thus, 
potentially overcoming two major barriers to exercise. As typical low-volume HIT 
protocols require 47-60% lower time commitment to MICT sessions, this may make 
HIT a more attractive training strategy to potentially increase exercise uptake and 
adherence in people with type 1 diabetes. The efficacy of long term HIT programmes 
will have to be explored in people with type 1 diabetes to determine whether this is 
an effective and time-efficient strategy to improve health. Furthermore, the effects of 
HIT in the non-fasted state have not been investigated. 
The major strength of this investigation lies in the strict dietary standardisation 
during the CGMS period and the fact that the exercise sessions were performed at 
the same time of day, in the same nutritional state. Another strength is that by using 
CGMS we were able to study the individuals under free-living conditions, and 
thereby take an ecologically valid approach to investigate glucose levels following 
exercise. We also acknowledge that there are some limitations that will need to be 
addressed with further research. Firstly, we did not record insulin dose during the 
CGMS period and participants were not blinded to the CGMS so they may have 
corrected their insulin dosage or taken carbohydrate to prevent lows if they felt it was 
necessary. The fact that there were no differences in food intake between the days 
lessens the chance that change in intake could be the cause. Secondly, the small 
sample size makes it difficult to draw conclusions that can be applied to the wider 
type 1 diabetes community. However, the sample size is in line with previous 
investigations that have compared the glycaemic effects of different exercise 
intensities in people with type 1 diabetes (16-18). There were three occasions where 
participants arrived to the laboratory with a blood glucose of <7 mmol/L on one trial 
so needed to consume ~20g CHO before exercising for safety reasons. This 
highlights the difficultly of testing people with type 1 diabetes. However, excluding 
these participants from the statistical analyses made no difference to the results so 
their data were kept in the final analysis. Finally, the MICT was only 30 minutes in 
duration so we do not know the effects of prolonged (>30 minutes) MICT sessions as 
this may lead to eventual falls in glycaemia and risk of hypoglycaemia. However, 30 
minutes MICT sessions are in line with the current exercise recommendations of 30 
minutes on 5 days of the week (1).  
In conclusion, this is the first study to demonstrate that there is no increased 
risk of hypoglycaemia over the 24-hour period or nocturnal period following a single 
bout of HIT or 30 minutes of MICT in the fasted state, compared to a day of no 
exercise in individuals with type 1 diabetes. Secondly, blood glucose concentration is 
unchanged across HIT and MICT when undertaken following an overnight fast and 
having omitted short-acting insulin. Therefore, we recommend that in the fasted state, 
provided blood glucose starts between 7-14 mmol/L, carbohydrate is not needed for 
HIT or a 30 minute MICT session. As HIT may offer a time-efficient and safe 
alternative for people with type 1 diabetes, future research should explore the 
efficacy of longer-term training programmes. 
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Table 1 - Summary of continuous glucose monitor data  
 CON               HIT                      MICT 
24-hr period    
Mean glucose (mmol/L) 9.2 ± 0.6 9.0 ± 0.4 9.5 ± 0.5 
CV (%) 39 ± 2 39 ± 3 38 ± 3 
Time in level 1 
hypoglycaemia (%) 
5.7 ± 1.4 7.5 ± 3.2 4.9 ± 2.0 
Time in level 2 
hypoglycaemia (%) 
1.1 ± 0.5 3.1 ± 1.9 1.4 ± 0.7 
Time in range (%) 60.5 ± 5.0 58.1 ± 3.6 59.3 ± 4.8 
Time in hyperglycaemia  
(%) 
33.7 ± 5.4 34.2 ± 3.6 35.8 ± 5.4 
Incidence of level 1 
hypoglycaemia 
1.8 ± 0.4 2.2 ± 0.6 1.6 ± 0.5 
Incidence of level 2 
hypoglycaemia 
0.6 ± 0.3 0.8 ± 0.4 0.6 ± 0.2 
Incidence of 
hyperglycaemia 
2.7 ± 0.3 3.1 ± 0.3 2.9 ± 0.3 
Nocturnal period    
Mean glucose (mmol/L) 9.0 ± 1.0 9.0 ± 0.7 9.3 ± 0.9 
CV (%) 25 ± 4 28 ± 5 19 ± 4 
Time in level 1 
hypoglycaemia (%) 
8.9 ± 4.8 8.0 ± 3.6 7.9 ± 4.7 
Time in level 2 
hypoglycaemia (%) 
1.5 ± 1.0 3.8 ± 2.4 4.0 ± 2.7 
Time in range (%) 59.5 ± 9.7 56.8 ± 8.2 58.5 ± 8.8 
Time in hyperglycaemia 
(%) 
31.3 ± 10.2 35.1 ± 8.7 33.3 ± 9.8 
Incidence of level 1 
hypoglycaemia 
0.4 ± 0.2 0.5 ± 0.3 0.4 ± 0.2 
Incidence of level 2 
hypoglycaemia 
0.1 ± 0.1 0.3 ± 0.2 0.2 ± 0.2 
Incidence of 
hyperglycaemia 
0.6 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 
  
Summary of continuous glucose monitor data for the 24-hour period (08:00-08:00h) 
and nocturnal period (24:00-06:00h) for the control day with no exercise (CON) and 
the days on which HIT and MICT were performed. Level 1 hypoglycaemia (≤3.9 
mmol/L), level 2 (severe) hypoglycaemia (≤2.9 mmol/L), target range (4-10 mmol/L) 
and hyperglycaemia (≥10 mmol/L). Data are presented as mean ± SEM. There were 
no differences in any of the factors between the conditions (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
